Health Care & Life Sciences » Biotechnology | RELIEF THERAPEUTICS Holding AG

RELIEF THERAPEUTICS Holding AG

RELIEF THERAPEUTICS Holding AG
Stock Exchange SIX Swiss Exchange
EPS
CHF0
Market Cap
CHF3.34 M
Shares Outstanding
2.11 B
Public Float
2 B

Profile

Address
Avenue de Sécheron 15
Geneva Geneve (Geneva) 1202
Switzerland
Employees -
Website http://www.relieftherapeutics.com
Updated 07/08/2019
RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology, which engages in the drug development and discovery business. Its products include pipeline, indications, compounds and clinical trials. The company was founded in June 2016 and is headquartered in Geneva, Switzerland.

Financials

View All
Created with Highcharts 5.0.14RELIEF THERAPEUTICS Holding AGNet Income. Fiscal year is January-December. All values CHF Thousands.12 22412 2247 2517 251868618 34518 3452 8872 88743643620132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14RELIEF THERAPEUTICS Holding AGSales/Revenue. Fiscal year is January-December. All values CHF Thousands.20 80420 804000016160056556520132014201520162017201805k10k15k20k25k

Raghuram Selvaraju
Chairman
Michel Dreano
Director & Chief Business Officer